{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-317642","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.846961+00:00","generated_at":"2026-05-16T13:23:31.525882+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tenaya Therapeutics prices $60M public offering of 50M units at $1.20/unit; warrants at $1.50","bullets":["Gross proceeds ~$60M from 50M units, each unit = 1 share + 1 warrant (5-yr, $1.50 exercise).","Underwriters: Leerink Partners, Piper Sandler, LifeSci Capital. Closing expected Dec 15, 2025.","Proceeds to fund development of TN-201 and TN-401 and for working capital and general purposes.","Warrant coverage at 100%; shares and warrants immediately separable on issuance.","60-day lockup for officers, directors, and certain stockholders unless consent is given."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-317642","json":"https://secwatch.observer/filing/0001193125-25-317642.json","markdown":"https://secwatch.observer/filing/0001193125-25-317642.md","text":"https://secwatch.observer/filing/0001193125-25-317642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000119312525317642/0001193125-25-317642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000119312525317642/d67398d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:23:31.525882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}